DYGIAD-1

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameDYGIAD-1

Drug Alias Namehumanized ATA antibodies (Enlyton)HuCC49deltaCH2ATA-1DYGIAD-1

ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionPositron-emission tomography enhancers

TargetsUpdating

Therapy Area/IndicationsAdenocarcinomaNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEnlyton

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesEnlyton

Active IndicationsN/A

Inactive IndicationsAdenocarcinomaNeoplasms

Other Information

ATC CodeN/A